scispace - formally typeset
Open AccessJournal ArticleDOI

Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine.

C. A. Carne, +6 more
- 04 Apr 1987 - 
- Vol. 294, Iss: 6576, pp 866-868
Reads0
Chats0
TLDR
This study shows the impact that coincident HIV infection may have on an otherwise efficacious vaccine and the efficacy of this and other vaccines in patients infected with HIV needs to be studied urgently.
Abstract
Thirty five homosexual men (17 positive for antibody to the human immunodeficiency virus (HIV) and 18 consistently negative) were vaccinated against hepatitis B virus infection. Eight of the 17 seropositive patients failed to develop detectable hepatitis B surface antibody within three months of the third injection compared with only one of the 18 seronegative patients (p less than 0.01). HIV infection is prevalent in the developed world in groups at risk for hepatitis B infection and in certain Third World countries where widespread vaccination programmes exist. This study shows the impact that coincident HIV infection may have on an otherwise efficacious vaccine. The efficacy of this and other vaccines in patients infected with HIV needs to be studied urgently.

read more

Citations
More filters
Journal ArticleDOI

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

TL;DR: HIV induces severe immunological abnormalities in T cells, B cells, and antigen-presenting cells early in infection before CD4+ T cell numbers start to decline, suggesting that impaired immunological function in subclinically HIV- infected patients may have clinical implications for vaccination strategies.
Journal ArticleDOI

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

TL;DR: HIV-1 infection was associated with reduced alanine aminotransferase elevations during the first 36 months of follow-up of men who became HBV carriers, suggesting inactivated hepatitis B vaccine may temporarily impair the immune response to HBV infection in HIV-1-infected persons.
Journal ArticleDOI

Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B.

TL;DR: Because hepatitis B vaccination has a key role in the control of hepatitis B, properties of this vaccine, its effectiveness in pre-ex exposure and post-exposure settings, duration of protection after vaccination and the need of booster doses are discussed.
Journal ArticleDOI

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.

TL;DR: Based on the results of this study, the best current strategy for hepatitis B vaccination in HIV patients would be to use a double dose as a primary series when the viral load is likely to be low and CD4> or = 350, when there is probably to be an adequate immune response.
References
More filters
Journal ArticleDOI

Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

TL;DR: The scope of immune dysfunction in the acquired immunodeficiency syndrome involves B cells as well as T cells, and it is concluded that the manifestations of B-cell hyperreactivity, such as hypergammaglobulinemia, seen in these patients are due to an in vivo polyclonal activation of B cells.
Journal ArticleDOI

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

TL;DR: It is confirmed that a highly purified, formalin‐inactivated vaccine against hepatitis B prepared from HBsAg positive plasma, is safe immunogenic, and highly efficacious, and over 95% of vaccinated subjects developed antibody against the surface antigen.
Journal ArticleDOI

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

TL;DR: Screening followed by vaccination of homosexual men and vaccination without prior screening of surgical residents would result in savings of medical costs, and neither screening nor vaccination is the lowest-cost strategy for the general population.
Related Papers (5)